Related Experiment Video
Updated: Jul 25, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Mutations in the vitamin D receptor gene in three kindreds associated with hereditary vitamin D resistant rickets
F J Cockerill1, N S Hawa, N Yousaf
1Department of Medicine, University College London Medical School, Middlesex Hospital, United Kingdom.
Abstract:
Hereditary vitamin D resistant rickets has been associated with a number of mutations within the DNA and ligand binding domains of vitamin D receptors (VDR). The aim of our study was to identify and characterize the causative mutations in three kindreds with this condition. Resistance of 1,25(OH)2D3 was confirmed in cultured skin fibroblasts in which there was no induction of 24-hydroxylase activity; binding of 1,25(OH)2D3 to VDR was undetectable in patients 1 and 2, but normal in patients 3 and 4. The coding region of the VDR gene was sequenced to seek mutations. A mutation in the VDR gene of patient 1 resulted in a STOP codon, patient 2 showed a 56 bp deletion leading to frameshift and premature termination of VDR; a point mutation of A to C lying within the hormone-binding domain was shown for patients 3 and 4, who were siblings. Transactivation studies confirmed that these were functional mutations. Gel shift assays using nuclear extract from patient 3 demonstrated that the mutation that altered a conserved amino acid (glutamine-259) known to be involved in heterodimerization with other nuclear receptors affected protein: protein interactions.
Insights
Genetic mutations in the vitamin D receptor (VDR) gene cause hereditary vitamin D resistant rickets. Our study identified specific VDR mutations, including STOP codons and deletions, explaining this rare genetic disorder.
Area of Science:
- Genetics
- Endocrinology
- Molecular Biology
Background:
- Hereditary vitamin D resistant rickets is linked to mutations in the vitamin D receptor (VDR) gene.
- These mutations affect critical domains of the VDR, including DNA and ligand binding sites.
Purpose of the Study:
- To identify and characterize the specific mutations in the VDR gene responsible for hereditary vitamin D resistant rickets in three families.
- To confirm the functional impact of these identified mutations on VDR activity.
Main Methods:
- Cultured skin fibroblasts were used to assess resistance to 1,25(OH)2D3 and 24-hydroxylase activity.
- DNA sequencing of the VDR gene coding region was performed to detect mutations.
- Transactivation studies and gel shift assays were employed to evaluate the functional consequences of the mutations.
Main Results:
- Patients 1 and 2 had undetectable 1,25(OH)2D3 binding to VDR due to a STOP codon mutation and a frameshift deletion, respectively.
- Patients 3 and 4, siblings, exhibited a point mutation in the VDR hormone-binding domain, affecting protein interactions.
- Functional studies confirmed that all identified mutations impaired VDR activity.
Conclusions:
- Specific mutations in the vitamin D receptor (VDR) gene, including premature termination and hormone-binding domain alterations, cause hereditary vitamin D resistant rickets.
- These genetic defects disrupt VDR function, leading to impaired response to vitamin D and the associated clinical condition.
Related Concept Videos
Pedigree Analysis
Sex-linked Disorders
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

